[Reasons for delayed and discontinued therapy in age-related macular degeneration].

about

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

Item

http://www.wikidata.org/entity/Q50013368

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@en

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@nl

type

Item

label

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@en

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@nl

prefLabel

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@en

[Reasons for delayed and discontinued therapy in age-related macular degeneration].

@nl

P1476

[Reasons for delayed and discontinued therapy in age-related macular degeneration]

@en

P2093

B Heimes

http://www.w3.org/2001/XMLSchema#string

D Pauleikhoff

http://www.w3.org/2001/XMLSchema#string

F G Holz

http://www.w3.org/2001/XMLSchema#string

J Bouws

http://www.w3.org/2001/XMLSchema#string

J Loss

http://www.w3.org/2001/XMLSchema#string

R P Finger

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of the intensity of fear on patient's delay regarding health care seeking behavior: a systematic review

Survey of the prevalence of immunization non-compliance due to needle fears in children and adults.

Presentation delay in patients affected with exudative age-related macular degeneration.

Traveling towards disease: transportation barriers to health care access.

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.

Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration.

Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.

[Compliance of age related macular degeneration patients undergoing anti-VEGF therapy : Analysis and suggestions for improvement].

[Delayed treatment initiation of more than 2 weeks. Relevance for possible gain of visual acuity after anti-VEGF therapy under real life conditions (interim analysis of the prospective OCEAN study)].

P2888

s00347-017-0610-z

P304

1035-1041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00347-017-0610-Z

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Maximilian Wintergerst

P577

2018-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29138977

http://www.w3.org/2001/XMLSchema#string